According to OncoCyte 's latest financial reports the company's current earnings (TTM) are $0.44 M. In 2022 the company made an earning of $2.71 M an increase over its 2021 earnings that were of -$73.36 M.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2023 (TTM) | $0.44 M | -83.47% |
2022 | $2.71 M | -103.7% |
2021 | -$73.36 M | 135.23% |
2020 | -$31.19 M | 39.06% |
2019 | -$22.43 M | 42.35% |
2018 | -$15.76 M | -18.68% |
2017 | -$19.38 M | 73.46% |
2016 | -$11.17 M | 27.86% |
2015 | -$8.74 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | -$0.12 B | -24,772.61% | ๐บ๐ธ USA |